The origin of the first blood (also called 'primitive erythroid cells') and endothelial cells during embryogenesis has been the focus of investigation for over a century [1] . Both cell types originate synchronously from mesoderm. In mice, on embryonic day 7-7.5, mesodermal cells aggregate in the extraembryonic yolk sac to form blood islands that contain both primitive erythroid cells and vascular endothelial cells. Several theories have been put forth about the simultaneous development of these two cell types -one is that both primitive erythroid and endothelial cells originate from a common precursor, termed the hemangioblast ( Figure 1A ). Another theory is that they differentiate -possibly stemming from a hemangioblastconcomitantly but separately, but the blood precursors require signals from the embryonic endothelial cells ( Figure 1C ). Alternatively, mesenchymally derived primitive endothelial cells could develop slightly earlier, with a subset subsequently differentiating into primitive erythroid cells, similarly to the hemogenic endothelium generating the multilineage 'definitive' hematopoietic stem and progenitor cells later in development ( Figure 1B) . While data exist supporting all models (discussed below), an interesting spontaneous zebrafish mutation was discovered in a semi-wild population obtained from an Indonesian fish farm. The mutant cloche, named for its bell-shaped heart, lacks both (most) hematopoietic cells and (most) vasculature, but no other mesodermal lineages [2] . Consequently, if the gene defective in this mutant were identified, this would shed light on the molecular basis of the bipotential hemangioblast. Over two decades later, recently published in Nature in a tour de force of molecular biology, Didier Stainier, who initially described the mutant, and colleagues now report the long-awaited cloning of the gene defective in cloche, and identified the transcription factor npas4l [3] .
Why did it take so long? It was the telomeric location of cloche combined with its very transient early expression during embryogenesis that thwarted scientists for years. Only high-resolution genetic mapping, state-of-the-art highsensitivity next-generation sequencing technology, an improved annotation of the zebrafish genome released in May 2015, together with efficient gene knockout technologies made it possible for this group to clone cloche [3] . The foundation for this success was laid in 2000, when the Stainier laboratory genetically mapped the cloche mutation to one of the telomeric regions of chromosome 13 using 2,359 mutant embryos. Due to the paucity of genetic markers in that region, new ones had to be first identified and, eventually, a microsatellite marker that became available to the authors could be mapped within an estimated 0.4 cM proximal to the cloche mutation, corresponding to a genomic region just under 300 kb [4] . Building on the previous mapping effort, for the present work, the authors genotyped an additional 7,920 mutant embryos. Of note, normally 1,500-2,500 embryos would yield enough resolution, but due to highly unreliable genome assembly for this telomeric region so many more mutants were required. This strategy resulted in the identification of an additional four genetic markers linked to the cloche mutation, narrowing down the number of possible candidates.
Still, the available physical map displaying all currently known genes at the telomere of chromosome 13 did not match the genetic map, making it possible that there were more unidentified genes in the region. Based on their previously established genetic marker linkage to the cloche mutation, Reischauer, Stone, Villasenor and colleagues resorted to simultaneously extracting DNA and RNA from many individual embryos, and pooling their RNA after genotyping linked markers to find downregulated transcripts in the mutants. The authors chose to harvest the embryos at the end of gastrulation, before the first phenotype could be observed in cloche mutants. This time point proved critical, as we now know that cloche is only expressed during a brief time window, peaking at the end of gastrulation. Deep sequencing of total RNA and poly(A)-enriched RNA, followed by mapping of the transcripts to the whole-genome assembly and EST libraries resulted in 19 old and new candidate genes. When the Stainier lab systematically knocked out all of them, first using TALENs and then CRISPR/Cas technology, only one candidate phenocopied cloche. It is now clear what prevented the identification of this gene before -it was only partially contained on a genomic 'scaffold' that could never be assigned to a chromosome.
The novel gene has been named npas4-like (npas4l) based on sharing some limited homology with human NPAS4, a basic helix-loop-helix-PER-ARNT-SIM domain (bHLH-PAS) transcription factor involved in the development of inhibitory neuronal synapses [5] . Phylogenetic analysis revealed the presence of npas4l only from lampreys to birds, but missing in mammals. And while human NPAS4 was able to rescue a cloche mutant to the same extent as zebrafish npas4l [3] , mice deficient for Npas4 survive into adulthood [5] , making a strong hemato-vascular defect in these mice unlikely. Thus, it might be speculated that a novel or several known mammalian NPAS proteins act redundantly to replace npas4l function -an exciting area for future studies.
The identification of npas4l as cloche raises many new questions -probably most interestingly, does this discovery shed light on the hemangioblast, the existence of which is still debated? In mouse and human embryonic stem cell differentiation systems, a progenitor with both endothelial and hematopoietic potential was identified [6, 7] , and this progenitor might also harbor cardiovascular potential [8] . This is worth noting, as cloche mutants completely lack endocardium, accompanied by an expansion of heart-forming regions in the anterior lateral plate mesoderm [9] . In vivo, single cells isolated from early gastrulating mouse embryos could produce both endothelial and blood cells, but also smooth muscle cells, indicating a multipotential rather than a bipotential progenitor [10] . More recently, retrospective clonal analysis that allowed tracking of the progeny of single cells without interfering with normal development showed that endothelial and primitive erythroid cells differentiate through different routes [11] . Also, in zebrafish, single-cell fate mapping studies demonstrated that the majority of cells labeled at the blastula or gastrula stages gave rise to either endothelial or blood cells. However, importantly, a fraction of labeled cells resulted in both (but no other) cell types, pointing to a subset of mesodermally derived cells that become bipotential hemangioblasts [12] . This could also involve a specialized hemogenic endothelium as an intermediate stage, evidence for which has accumulated recently also for primitive hematopoiesis [13] . Now that cloche has been cloned, the Stainier laboratory were able to take the first steps to directly address how early cloche (npas4l) itself functions. Knocking down both etv2 and tal1, two early markers of endothelial and, for tal1, also hematopoietic differentiation, did not alter npas4l expression. Conversely, overexpression of npas4l led to premature and ectopic expression of both genes during gastrulation, positioning npas4l upstream of these two genes. It will be interesting to relate npas4l function to the expression of other drivers of endothelial and blood development. For instance, whereas expression of many of these genes is virtually absent in cloche mutants, the vascular ETS-domain transcription factor fli1 is initially expressed in the posterior lateral mesoderm from which trunk vasculature is derived (as well as primitive erythroid cells) [4, 14, 15] . Indeed, some endothelial-like cells still remain in the lower trunk and tail regions in cloche mutants [2, 16] . Furthermore, an activated form of fli1 (fli1-VP16) led to ectopic tal1 expression in wild-type embryos but did not rescue tal1 in cloche mutants, indicating that fli1 might act upstream or in parallel to npas4l [15] .
As the proposed master regulator of the hemangioblast, can npas4l induce both endothelial and hematopoietic fates? This question is probably more difficult to answer. It has been previously shown that overexpression of tal1 expands expression of gata1 (a marker of the primitive erythroid lineage) in wild-type embryos, and rescues blood and vascular defects in cloche mutants [17, 18] . However, in the present work, injection of npas4l RNA into wild-type embryos, while increasing tal1 expression, did not lead to more gata1-expressing cells. Intriguingly, npas4l overexpression also did not rescue gata1 expression in cloche mutants. This result could be explained by the possibility that npas4l needs to be downregulated just before the emergence of gata1-expressing erythroid progenitors, which might be linked to its cell non-autonomous function in erythroid specification. Previously, in a large effort of performing over 1,500 reciprocal transplant experiments of cloche mutant cells to wild-type embryos, the same laboratory found cloche to contribute cell non-autonomously to the specification of primitive erythroid progenitors before the onset of gata1 expression. Once the erythroid lineage was established, however, cloche contributed cellautonomously [19] . In contrast, the endothelial defect in cloche mutants was found to be completely cell-autonomous, consistent with the ability of npas4l to rescue expression of flk1, one of the VEGF receptors acting downstream of fli1 and etv2, in cloche mutants [2, 19] . The authors' speculation back then might explain this result -cloche could be a transcription factor required for endothelial cells to differentiate or secrete a factor to provide the microenvironment (A) Bipotential hemangioblast giving rise to primitive erythroid and endothelial cells. Adapted from [20] . (B) Endothelial progenitors subspecialize to form hemogenic endothelium as the source of primitive erythroid cells. Adapted from [13] . (C) Endothelial and erythroid progenitors differentiate separately, but the erythroid progenitors require signals from the endothelial 'microenvironment'. Adapted from [19] .
necessary for differentiation of hematopoietic progenitors into gata1-expressing cells [19] . With npas4l, the long-awaited gene responsible for the cloche phenotype has been cloned. Its identification allows for a thorough functional analysis, including the dissection of its upstream regulators and downstream targets, both intra-and extra-embryonic. This will critically further our understanding of the events that take place in the specialization of mesoderm to initiate endothelial, cardiovascular, and hematopoietic differentiation. It will also assist efforts to differentiate pluripotent stem cells into endothelial and hematopoietic cells in vitro for clinical use.
A new study shows that nocturnal courtship vocalization is regulated by a circadian rhythm and potentiated by melatonin at multiple timescales. These findings are in contrast to those in diurnal vocalizers and provide a striking example of melatonin's niche-specific functions.
Temporal patterns shape social behavior at many levels. Time parameters define the rate, frequency, and amplitude signatures of social displays, indicate species, sex, and reproductive state, and mark meaningful individual variation among signalers. Social behavior also varies on both daily and seasonal timescales. Areas throughout the brain control these different temporal functions and depend on external cues, especially photoperiod, to adjust and synchronize these biological rhythms. To do this, information about the prevailing light cycle is converted into an endocrine signal in the form of melatonin by the
